Kayikcioglu, Meral https://orcid.org/0000-0003-3692-5227
Article History
Accepted: 18 January 2021
First Online: 17 February 2021
Compliance with Ethical Standards
:
: Meral Kayikcioglu has received research grants for investigator-initiated trials from a variety of companies including Amgen, Amyryt Pharma, and AstraZeneca; investigator fees for RCTs from Sanofi, Esperion, and Amgen; and honorarium for advisory boards for Amgen, Novartis via her institution (Ege University) within the last 3 years.
: This article does not contain any studies with human or animal subjects performed by any of the authors.